ICM
QDEL icon

Invenomic Capital Management’s QuidelOrtho QDEL Stock Holding History

Invenomic Capital Management’s Portfolio QDEL Stock Details QDEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-76,267
Closed -$1.25M – 150
2026
Q1 		$1.25M Buy
+76,267
New +$1.87M 0.06% 138
2024
Q1 		– Sell
-503,991
Closed -$37.1M – 182
2023
Q4 		$37.1M Buy
+503,991
New +$34.1M 1.69% 15
2023
Q3 		– Sell
-38,218
Closed -$3.17M – 161
2023
Q2 		$3.17M Sell
38,218
-506
-1% -$44.3K 0.16% 105
2023
Q1 		$3.45M Buy
38,724
+891
+2% +$77.5K 0.19% 110
2022
Q4 		$3.24M Buy
37,833
+24,363
+181% +$2.06M 0.22% 106
2022
Q3 		$963K Buy
+13,470
New +$1.21M 0.08% 141

Other funds holding QDEL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invenomic Capital Management's QDEL Position: Q2 2026 in Review

Invenomic Capital Management sold out of QuidelOrtho (QDEL) in Q2 2026, closing a stake of 76,267 shares — an estimated $1.25M sold.

Invenomic Capital Management first reported a position in QDEL in Q3 2022 and held it in 6 quarters. The position peaked at $37.1M in Q4 2023. 246 funds tracked by Wall St. Rank hold QDEL as of Q2 2026.

  • Invenomic Capital Management reported no remaining QuidelOrtho position as of Q2 2026 after selling out during the quarter.
  • Invenomic Capital Management sold 76,267 QuidelOrtho shares in Q2 2026, an estimated $1.25M.
  • Invenomic Capital Management first reported a position in QuidelOrtho in Q3 2022 and held it in 6 quarters.
  • Invenomic Capital Management's QuidelOrtho position peaked at $37.1M in Q4 2023.
  • 246 funds tracked by Wall St. Rank held QuidelOrtho as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.